These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A substance P antagonist also inhibits specific binding and mitogenic effects of vasopressin and bombesin-related peptides in Swiss 3T3 cells. Zachary I; Rozengurt E Biochem Biophys Res Commun; 1986 May; 137(1):135-41. PubMed ID: 2424443 [TBL] [Abstract][Full Text] [Related]
6. Characterization of intrathecal vasopressin-induced antinociception, scratching behavior, and motor suppression. Thurston CL; Campbell IG; Culhane ES; Carstens E; Watkins LR Peptides; 1992; 13(1):17-25. PubMed ID: 1535707 [TBL] [Abstract][Full Text] [Related]
7. Scratching behavior induced by bombesin-related peptides. Comparison of bombesin, gastrin-releasing peptide and phyllolitorins. Masui A; Kato N; Itoshima T; Tsunashima K; Nakajima T; Yanaihara N Eur J Pharmacol; 1993 Jul; 238(2-3):297-301. PubMed ID: 7691621 [TBL] [Abstract][Full Text] [Related]
8. Substance P elicited grooming in the mouse: behavioral and pharmacological characteristics. Katz RJ Int J Neurosci; 1980; 10(2-3):187-9. PubMed ID: 6154021 [TBL] [Abstract][Full Text] [Related]
9. Effects of dopamine D1 and D2 receptor agonists and antagonists on bombesin-induced behaviors. Merali Z; Piggins H Eur J Pharmacol; 1990 Dec; 191(3):281-93. PubMed ID: 2086245 [TBL] [Abstract][Full Text] [Related]
10. Short-term behavioral effects of posterior pituitary peptides in mice. Meisenberg G Peptides; 1981; 2(1):1-8. PubMed ID: 7243620 [TBL] [Abstract][Full Text] [Related]
11. Vasopressin antagonists block peripheral as well as central vasopressin receptors. De Wied D; Gaffori O; Van Ree JM; De Jong W Pharmacol Biochem Behav; 1984 Sep; 21(3):393-400. PubMed ID: 6093152 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and some pharmacological properties of new V1/V2 antagonists of arginine-vasopressin with structural changes at their N-terminals. Lammek B; Konieczna E; Wierzba T; Wang YX; Gavras H Pol J Pharmacol Pharm; 1992; 44(2):179-86. PubMed ID: 1409118 [TBL] [Abstract][Full Text] [Related]
13. Effects of bombesin on behavior. Cowan A; Khunawat P; Zhu XZ; Gmerek DE Life Sci; 1985 Jul; 37(2):135-45. PubMed ID: 2409426 [TBL] [Abstract][Full Text] [Related]
14. Neuromedin-induced excessive grooming/scratching behavior is suppressed by naloxone, neurotensin and a dopamine D1 receptor antagonist. Van Wimersma Greidanus TB; Maigret C Eur J Pharmacol; 1991 Dec; 209(1-2):57-61. PubMed ID: 1814760 [TBL] [Abstract][Full Text] [Related]
15. (D-Phe12) bombesin and substance P analogues function as central bombesin receptor antagonists. Merali Z; Merchant CA; Crawley JN; Coy DH; Heinz-Erian P; Jensen RT; Moody TW Synapse; 1988; 2(3):282-7. PubMed ID: 2463692 [TBL] [Abstract][Full Text] [Related]
16. Neurolepticlike actions of l-methadone: effect on mescaline-induced altered behavior and on tissue levels of mescaline in mice. Shah NS; Hudnall SD; May D; Eargle D; Yates J Biol Psychiatry; 1979 Aug; 14(4):587-94. PubMed ID: 486615 [TBL] [Abstract][Full Text] [Related]
17. Vasopressin into the preoptic area increases grooming behavior in mice. Lumley LA; Robison CL; Chen WK; Mark B; Meyerhoff JL Physiol Behav; 2001 Jul; 73(4):451-5. PubMed ID: 11495648 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of centrally injected AVP on heart rate, core temperature, and behavior in rats. Diamant M; De Wied D Am J Physiol; 1993 Jan; 264(1 Pt 2):R51-61. PubMed ID: 8430886 [TBL] [Abstract][Full Text] [Related]
19. Heterologous desensitization of bombesin-induced mitogenesis by prolonged exposure to vasopressin: a post-receptor signal transduction block. Millar JB; Rozengurt E Proc Natl Acad Sci U S A; 1989 May; 86(9):3204-8. PubMed ID: 2541435 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of the vasopressin-enhancing effect on memory retrieval and relearning by a vasopressin V1 receptor antagonist in mice. Alescio-Lautier B; Rao H; Paban V; Devigne C; Soumireu-Mourat B Eur J Pharmacol; 1995 Dec; 294(2-3):763-70. PubMed ID: 8750743 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]